Trends in Uropathogenic <i>Escherichia coli</i> Genotype and Antimicrobial Resistance From 2019 to 2022 in a San Francisco Public Hospital Network
Steady ST prevalence and stable or decreased AMR prevalence masked significant increased fluoroquinolone resistance with ST131, which may represent unmeasured patient characteristics, bacterial factors, or new exposure to resistant ST131 in the community. Antimicrobial surveillance of UPEC at the ST level may be important for monitoring otherwise unnoticed AMR trends.
Authors
- H. Kim
- Padukudru Anand Mahesh (ORCID: https://orcid.org/0000-0003-1632-5945)
- Sean Joyce (ORCID: https://orcid.org/0000-0002-1820-4381)
- Henry F. Chambers (ORCID: https://orcid.org/0000-0001-5317-4491)
- Eva Raphael (ORCID: https://orcid.org/0000-0003-2854-0247)
- Cheyenne Belmont
- Abraham Soto
- Kavitha Ravi (ORCID: https://orcid.org/0000-0001-7310-4714)
- Noah Rubin-Saika
- Matthew Elises
Institutions
- JSS Academy of Higher Education and Research (IN)
- Berkeley College (US)
- University of California, San Francisco (US)
- Rosalind Franklin University of Medicine and Science (US)
- Yale University (US)
- Yale New Haven Health System (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/ofid/ofaf579
- Citations
- 1
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35